China Universal Asset Management »

Axsome Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $830k 9.2k 89.87
2024-06-30 $449k 5.6k 80.50
2024-03-31 $726k 9.1k 79.80
2023-12-31 $436k 5.5k 79.59
2023-09-30 $84k 1.2k 69.89
2023-06-30 $41k 571 71.86
2023-03-31 $36k 589 61.68
2022-12-31 $34k 441 77.13
2022-09-30 $17k 377 45.09

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Axsome Therapeutics

BlackRock
Fairmount Funds Management
BVF
RA Capital Management
Geode Capital Management
Eventide Asset Management
Perceptive Advisors
Alethea Capital Management
Bank of America Corporation
Invesco
Susquehanna International
Point72 Asset Management
Sofinnova Ventures
Citadel Advisors
Partner Fund Management

View all funds holding Axsome Therapeutics